• The fund’s LPs include sovereign wealth funds, corporate pensions, financial institutions, university endowments, medical institutions, foundations, family offices and funds-of-funds
• venBio Fund V began fundraising in mid-April
• The VC firm was founded in 2011

venBio, a San Francisco-based venture capital firm, has closed fifth fund at $528 million.

venBio Fund V will invest in life science companies.

The fund’s limited partners include sovereign wealth funds, corporate pensions, financial institutions, university endowments, medical institutions, foundations, family offices and funds-of-funds.

venBio Fund V began fundraising in mid-April.

On the fundraising, managing partner Dr. Corey Goodman said in a statement, “Our portfolio is directly impacting patient lives, and we could not have achieved this without the ongoing commitment from our limited partners. Fund V is structured to enable us to continue our proven approach of being highly selective in company building, while doubling down on winners around key inflection points, including in crossover rounds and at IPO.”

venBio was founded in 2011.